Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.kabradrugs.com | |
Market Cap | 1.83 Cr. | |
Enterprise Value(EV) | 2.98 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.53 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.90 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | -1.21 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | -3.47 | Calculated using Price: 4.18 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.44 Cr. | 4,388,600 Shares |
FaceValue | 10 | |
Company Profile | ||
The company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products. |
1 Day |
|
-5.00% |
1 Week |
|
-5.00% |
1 Month |
|
-10.30% |
3 Month |
|
-18.83% |
6 Month |
|
+10.29% |
1 Year |
|
-23.86% |
2 Year |
|
-3.69% |
5 Year |
|
+68.55% |
10 Year |
|
-5.43% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 2.99 | 2.55 | 1.05 | 5.02 | -171.40 | -144.20 | -2,869.33 | |||
Return on Capital Employed (%) | 4.82 | 3.52 | 5.81 | 7.49 | -80.09 | -19.67 | -8.82 | -27.33 | -27.96 | |
Return on Assets (%) | 0.97 | 0.79 | 0.31 | 1.67 | -58.30 | -10.36 | -4.11 | -12.78 | -17.39 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 3 | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | -1 | |
Non Curr. Liab. | 2 | 3 | 2 | 1 | 0 | 0 | |||||
Curr. Liab. | 4 | 3 | 4 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | |
Minority Int. | |||||||||||
Equity & Liab. | 9 | 9 | 9 | 6 | 2 | 1 | 1 | 1 | 1 | 1 | |
Non Curr. Assets | 3 | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | |
Curr. Assets | 6 | 6 | 6 | 4 | 1 | 1 | 1 | 1 | 1 | 1 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 9 | 9 | 9 | 6 | 2 | 1 | 1 | 1 | 1 | 1 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 11 | 8 | 10 | 8 | 2 | ||||||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Total Income | 11 | 8 | 10 | 8 | 2 | 0 | 0 | 0 | |||
Total Expenditure | -11 | -8 | -9 | -7 | -3 | 0 | 0 | 0 | 0 | 0 | |
PBIDT | 1 | 0 | 0 | 1 | -1 | 0 | 0 | 0 | 0 | 0 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | |||||||
Exceptional Items | -1 | ||||||||||
PAT | 0 | 0 | 0 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | -5 | 0 | 0 | 0 | 0 | -1 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | |||
Cash Fr. Finan. | 2 | 0 | 1 | 0 | 0 | -1 | 0 | 0 | 0 | ||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fri, 06 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31st 2022. |
Sat, 31 Dec 2022
Closure of Trading Window Closure of Trading Window |
Mon, 14 Nov 2022
Board Meeting Outcome for Unaudited Financial Result For Quarter Ending 30Th September 2022 Pursuant To Regulation 33 Of The SEBI(LODR) Regulations 2015 In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 please find attached herewith unaudited financial result for quarter ended 30thSeptember 2022 |
Fri, 27 Jan 2023 |
|
|
|
|
|